Phase 2 – Prototype Development

Duration: 16th November 2022 to 16th March 2024  

During Phase 2 the Contractors will develop, demonstrate and test the performance of prototypes based on their Solution Designs from Phase 1.

Information for Contractors

Phase 2 Awards 

Budget of awarded contracts: 4.768.864 EUR

Proposals received: 14

Number of Contracts awarded: 11

Lot 1: Pre-Sequencing: 3

Lot 2: Sequencing:  Due to the insufficient number of tenders received, no contract was awarded for Lot 2 in Phase 1.

Lot 3: Bioinformatics Analysis: 4

Lot 4: Integrated Reporting: 4

Selected Contractors:

Lot 1: Pre-Sequencing 

Lead: Integrated DNA Technologies, BV
 
Lead: QIAGEN GmbH
 
TwistPlatomicsMGI – Project abstract
Lead: Twist Bioscience Corporation
 
 

Lot 3: Bioinformatics Analysis

Congenica L3 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
 
Cancer Analysis GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
EU Onco-Platform L3 – Project abstract 
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
 
PlatoDKFZCharité – Project abstract 
Lead: Platomics GmbH
Consortium members: Deutsches Krebforschungszentrum, Charité Universitätsmedizin Berlin
 

Lot 4: Integrated Reporting

Cancer Reporting GPAP – Project abstract
Lead: FUNDACIO CENTRE DE REGULACIO GENOMICA
Consortium members: Single tenderer
 
Congenica L4 – Project abstract
Lead: Congenica Limited BIC Wellcome Genome Campus
Consortium members: Single tenderer
 
EU Onco Platform L4 – Project abstract
Lead: BC Platforms AG
Consortium members: Euformatics Oy, Oncompass Medicine Hangary Kft.
 
tde4ngs – Project abstract 
Lead: fragmentiX Storage Solutions GmbH 
Consortium members: ID GmbH & Co. KgaA, Maxeler Technologies Ltd., Prime Force GmbH